Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 4/2023

06-10-2022 | Review

Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review

Auteurs: Rachel Cusatis, Joanna Balza, Zachary Uttke, Vishwajit Kode, Elizabeth Suelzer, Bronwen E. Shaw, Kathryn E. Flynn

Gepubliceerd in: Quality of Life Research | Uitgave 4/2023

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Cognitive dysfunction is a known complication following cellular therapies (CT), which can be assessed through performance based and patient-reported measures. We performed a systematic scoping review to assess self-reported cognitive function measures used among adult CT patients and describe long-term results, including associations with clinical outcomes.

Methods

Library databases were searched from inception to February 2020 according to PRISMA guidelines. Additional studies were identified through reference lists and trial protocols. Two members of the research team screened titles and abstracts and resolved discrepancies. Articles that met eligibility criteria continued to full-text review, with 25% double screening. Articles were removed if they (1) were not original research, peer-reviewed articles; (2) were the wrong disease, age, or treatment-specific patient population; (3) did not use patient-reported outcomes; (4) did not separately report cognitive function outcomes.

Results

Of the1952 articles, 56 were included. Twenty-one patient-reported measures of cognitive function were used; most frequently the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30), which includes a two-item cognitive function subscale (57%; n = 32). Thirteen studies collected performance-based and self-reported measures and of those (n = 6) who assessed associations found moderate correlations (range r = .13-.58). Longitudinal patterns showed declines in cognitive function soon after treatment (< 1 month) returning to baseline at 1 year. Cognitive function was often associated with other quality of life measures, chiefly depression (n = 5).

Conclusions

EORTC-QLQ-C30 is the most commonly used to measure, though there remain numerous measures used, including several measures with little previous validation and investigator developed items.
vorige artikel Time trade-off health state utility values for depression: a systematic review and meta-analysis
volgende artikel Updating our understanding of health-related quality of life issues in children with cancer: a systematic review of patient-reported outcome measures and qualitative studies
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Dietrich, J., Monje, M., Wefel, J., Meyers, C., & Pappas, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. The Oncologist, 13, 1285–1295.PubMedCrossRef
2.
Lee, D. W., et al. (2019). ASTCT Consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biology of Blood and Marrow Transplantation, 25, 625–638.PubMedCrossRef
3.
4.
Buchbinder, D., et al. (2018). 2018 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplantation, 535(53), 535–555.CrossRef
5.
Food, U. S., Administration, D., & Others. (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74, 65132–65133.
6.
Kamal, M., et al. (2021). Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor t cell therapy: A systematic review. Transplantation Cellular Therapy., 27(390), e1-390.e7.
7.
Maziarz, R. T., et al. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Advances, 4, 629–637.PubMedPubMedCentralCrossRef
8.
9.
Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926–934.PubMedCrossRef
10.
Saffer, B. Y., Lanting, S. C., Koehle, M. S., Klonsky, E. D., & Iverson, G. L. (2015). Assessing cognitive impairment using PROMIS® applied cognition-abilities scales in a medical outpatient sample. Psychiatry Research, 226, 169–172.PubMedCrossRef
11.
Iverson, G. L., Marsh, J. M., Connors, E. J., & Terry, D. P. (2021). Normative reference values, reliability, and item-level symptom endorsement for the PROMIS® v2.0 cognitive function-short forms 4a, 6a and 8a. Archives Clinical Neuropsychology, 36, 1341–1349.CrossRef
12.
Lai, J.-S., Wagner, L. I., Jacobsen, P. B., & Cella, D. (2014). Self-reported cognitive concerns and abilities: Two sides of one coin? Psycho-Oncology, 23, 1133–1141.PubMedPubMedCentralCrossRef
13.
14.
Garcia, S. F., et al. (2007). Standardizing patient-reported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative. Journal of Clinical Oncology, 25, 5106–5112.PubMedCrossRef
15.
Henneghan, A. M., et al. (2021). Measuring Self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group. JNCI J Natl Cancer Inst, 113, 1625.PubMedCrossRef
16.
Tricco, A. C., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169, 467–473.PubMedCrossRef
17.
A, E. et al. Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. in Abstracts of the 22nd Cochrane Colloquium 9 (John Wiley & Sons, 2014).
18.
Correa, D. D., et al. (2019). Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation. Journal of Neuro-oncology, 144, 553–562.PubMedPubMedCentralCrossRef
19.
Fann, J. R., Roth-Roemer, S., Burington, B. E., Katon, W. J., & Syrjala, K. L. (2002). Delirium in patients undergoing hematopoietic stem cell transplantation. Cancer, 95, 1971–1981.PubMedCrossRef
20.
Dean, H. F., et al. (2012). Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma. Bone Marrow Transplantation, 47, 1545–1551.PubMedCrossRef
21.
Deeg, H. J., et al. (1998). Long-term outcome after marrow transplantation for severe aplastic anemia. Blood, 91, 3637–3645.PubMedCrossRef
22.
Andrykowski, M. A., Henslee, P. J., & Barnett, R. L. (1989). Longitudinal assessment of psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplantation, 4, 505–509.PubMed
23.
24.
Bush, N. E., Donaldson, G. W., Haberman, M. H., Dacanay, R., & Sullivan, K. M. (2000). Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients. Biology of Blood and Marrow Transplantation, 6, 576–591.PubMedCrossRef
25.
Alaloul, F., Brockopp, D. Y., Andrykowski, M. A., Hall, L. A., & Al Nusairat, T. S. (2015). Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: Comparison with matched healthy group. Supportive Care in Cancer, 23, 2157–2164.PubMedCrossRef
26.
Schoulte, J. C., Lohnberg, J. A., Tallman, B., & Altmaier, E. M. (2011). Influence of coping style on symptom interference among adult recipients of hematopoietic stem cell transplantation. Oncology Nursing Forum, 38(5), 582–586.PubMedCrossRef
27.
Acaster, S., Gaugris, S., Velikova, G., Yong, K., & Lloyd, A. J. (2013). Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: A UK cross-sectional survey. Supportive Care in Cancer, 21, 599–607.PubMedCrossRef
28.
Harder, H., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183–192.PubMedCrossRef
29.
Schulz-Kindermann, F., et al. (2007). Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation, 3912(39), 789–799.CrossRef
30.
Booth-Jones, M., Jacobsen, P. B., Ransom, S., & Soety, E. (2005). Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplantation, 368(36), 695–702.CrossRef
31.
Sanders, J. E., et al. (2010). The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplantation, 454(45), 746–754.CrossRef
32.
Bishop, M. M., et al. (2007). Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. Journal of Clinical Oncology, 25, 1403–1411.PubMedCrossRef
33.
Caocci, G., et al. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Bone Marrow Transplantation, 17, 3637–3645.
34.
Jarden, M., Nelausen, K., Hovgaard, D., Boesen, E., & Adamsen, L. (2009). The effect of a multimodal intervention on treatment-related symptoms in patients undergoing hematopoietic stem cell transplantation: A randomized controlled trial. Journal of Pain and Symptom Management, 38, 174–190.PubMedCrossRef
35.
Ahmedzai, S. H., et al. (2019). Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37, 1617.PubMedPubMedCentralCrossRef
36.
Mayo, S., et al. (2016). Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone Marrow Transplantation, 516(51), 841–847.CrossRef
37.
El-Banna, M. M., et al. (2004). Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation. Oncology Nursing Forum, 31, 937–944.PubMedCrossRef
38.
Watson, M., et al. (2004). Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: Analysis of the UK Medical Research Council AML 10 Trial. European Journal of Cancer, 40, 971–978.PubMedCrossRef
39.
Wu, L. M., et al. (2012). Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psycho-Oncology, 21, 1175–1184.PubMedCrossRef
40.
Jacobs, S. R., Jacobsen, P. B., Booth-Jones, M., Wagner, L. I., & Anasetti, C. (2007). Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic stem cell transplant patients. Journal of Pain and Symptom Management, 33, 13–23.PubMedCrossRef
41.
Andrykowski, M. A., et al. (1990). Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: Relationship to dose of total body irradiation. Bone Marrow Transplantation, 6, 269–276.PubMed
42.
Sarkar, S., et al. (2014). Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transplantation, 499(49), 1217–1222.CrossRef
43.
Ghazikhanian, S. E., et al. (2017). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 522(52), 279–284.CrossRef
44.
Harder, H., et al. (2007). Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: Two-year follow-up results. European Journal of Cancer, 43, 2052–2059.PubMedCrossRef
45.
Larsen, J., Nordström, G., Ljungman, P., & Gardulf, A. (2007). Factors associated with poor general health after stem-cell transplantation. Supportive Care in Cancer, 15, 849–857.PubMedCrossRef
46.
Baker, F., Denniston, M., Zabora, J. R., & Marcellus, D. (2003). Cancer problems in living and quality of life after bone marrow transplantation. Journal of Clinical Psychology Medical Settings, 101(10), 27–34.CrossRef
47.
Molassiotis, A., Wilson, B., Blair, S., Howe, T., & Cavet, J. (2011). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20, 88–97.PubMedCrossRef
48.
Stewart, A. K., et al. (2013). A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: The National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial. Blood, 121, 1517–1523.PubMedPubMedCentralCrossRef
49.
Clavert, A., et al. (2017). Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 23, 140–146.PubMedCrossRef
50.
Velikova, G., et al. (2007). The EORTC QLQ-HDC29: A supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. European Journal of Cancer, 43, 87–94.PubMedCrossRef
51.
Jim, H. S. L., et al. (2012). Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer, 118, 3407–3416.PubMedCrossRef
52.
Gruters, A. A. A., et al. (2019). Association between proxy- or self-reported cognitive decline and cognitive performance in memory clinic visitors. Journal of Alzheimer’s Disease, 70, 1225–1239.PubMedCrossRef
53.
Howland, M., et al. (2017). Patient-rated versus proxy-rated cognitive and functional measures in older adults. Patient Related Outcome Measures, 8, 33.PubMedPubMedCentralCrossRef
54.
Sidana, S., et al. (2019). Patient experience of chimeric antigen receptor (CAR)-T cell Therapy vs. stem cell transplant: Longitudinal patient reported adverse events, cognition and quality of life. Blood, 134, 794.CrossRef
55.
Chakraborty, R., et al. (2019). Patient-reported outcomes with chimeric antigen receptor T Cell therapy: challenges and opportunities. Biology of Blood and Marrow Transplantation, 25, e155–e162.PubMedCrossRef
56.
Andresen, S., et al. (2012). The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leukaemia & Lymphoma, 53, 386–393.CrossRef
57.
Bartley, E. J., et al. (2014). Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation. Journal of Pain and Symptom Management, 48, 374–384.PubMedCrossRef
58.
Basinski, J. R., Alfano, C. M., Katon, W. J., Syrjala, K. L., & Fann, J. R. (2010). Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biology of Blood and Marrow Transplantation, 16, 824–831.PubMedPubMedCentralCrossRef
59.
Bonifazi, F., et al. (2019). GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: Final results of quality of life and long-term outcome analysis of a phase 3 randomised study. Lancet Haematol, 6, e89–e99.PubMedCrossRef
60.
Braamse, A. M. J., et al. (2014). Distress, problems and supportive care needs of patients treated with auto- or allo-SCT. Bone Marrow Transplantation, 492(49), 292–298.CrossRef
61.
Caocci, G., et al. (2006). Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: Quality of life, communication and ethical issues. Bone Marrow Transplantation, 372(37), 165–169.CrossRef
62.
Chang, G., Meadows, M. E., Orav, E. J., & Antin, J. H. (2009). Mental status changes after hematopoietic stem cell transplantation. Cancer, 115, 4625–4635.PubMedCrossRef
63.
64.
Crooks, M., Seropian, S., Bai, M., & McCorkle, R. (2014). Monitoring patient distress and related problems before and after hematopoietic stem cell transplantation. Palliative & Supportive Care, 12, 53–61.CrossRef
65.
Hacker, E. D., et al. (2006). Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncology Nursing Forum, 33, 614–624.CrossRef
66.
Epstein, J. B., et al. (2002). Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 3011(30), 785–792.CrossRef
67.
Ghazikhanian, S. E., et al. (2016). Cognitive problems following hematopoietic stem cell transplant: Relationships with sleep, depression and fatigue. Bone Marrow Transplantation, 52, 279–284.PubMedPubMedCentralCrossRef
68.
Harder, H., et al. (2005). Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study. European Journal of Cancer, 41, 1007–1016.PubMedCrossRef
69.
Hayden, P. J., et al. (2004). A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplantation, 346(34), 545–556.CrossRef
70.
Hendriks, M. G. J., & Schouten, H. C. (2002). Quality of life after stem cell transplantation: A patient, partner and physician perspective. European Journal of Internal Medicine, 13, 52–56.PubMedCrossRef
71.
Hjermstad, M. J., Holte, H., Evensen, S. A., Fayers, P. M., & Kaasa, S. (1999). Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplantation, 24, 911–918.PubMedCrossRef
72.
Hjermstad, M. J., Evensen, S. A., Kvaløy, S. O., Fayers, P. M., & Kaasa, S. (1999). Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: A prospective study. Journal of Clinical Oncology, 17, 706–718.PubMedCrossRef
73.
Hong, F., Bosco, J. L. F., Bush, N., & Berry, D. L. (2013). Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy. BMC Cancer, 13, 1–8.CrossRef
74.
Hung, Y. C., et al. (2014). Telephone-delivered nutrition and exercise counselling after auto-SCT: A pilot, randomised controlled trial. Bone Marrow Transplantation, 496(49), 786–792.CrossRef
75.
Jones, D., et al. (2013). Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer, 119, 4188–4195.PubMedCrossRef
76.
Kav, S., et al. (2009). Quality of life and difficulties of patients encountered after autologous stem cell transplantation. Journal of BUON, 14, 673–680.PubMed
77.
Naegele, M., et al. (2018). Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: A descriptive longitudinal study. Supportive Care in Cancer, 26, 833–841.PubMedCrossRef
78.
Persoon, S., et al. (2017). Randomized controlled trial on the effects of a supervised high intensity exercise program in patients with a hematologic malignancy treated with autologous stem cell transplantation: Results from the EXIST study. PLoS ONE, 12, e0181313.PubMedPubMedCentralCrossRef
79.
Wu, L. M., et al. (2014). Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life. Psycho-Oncology, 23, 1406–1414.PubMedCrossRef
80.
Wu, L. M., et al. (2019). A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors. Palliative & Supportive Care, 17, 396.CrossRef
Metagegevens
Titel
Patient-reported cognitive function among hematopoietic stem cell transplant and cellular therapy patients: a scoping review
Auteurs
Rachel Cusatis
Joanna Balza
Zachary Uttke
Vishwajit Kode
Elizabeth Suelzer
Bronwen E. Shaw
Kathryn E. Flynn
Publicatiedatum
06-10-2022
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-022-03258-0

Andere artikelen Uitgave 4/2023

Quality of Life Research 4/2023 Naar de uitgave

OriginalPaper

Health-related quality of life in various health conditions: two consecutive surveys of older Japanese adults

OriginalPaper

What is measured by the composite, single-item pain/discomfort dimension of the EQ-5D-5L? An exploratory analysis

OriginalPaper

The effects of greater frequency of two most prevalent bothersome acute respiratory symptoms on health-related quality of life in the 2020 US general population

OriginalPaper

Relationship between health-related quality of life and physical fitness in Norwegian adolescents

OriginalPaper

Patient-reported outcome (PRO) measurements in chronic and malignant diseases: ten years’ experience with PRO-algorithm-based patient-clinician interaction (telePRO) in AmbuFlex

OriginalPaper

Vision-related quality of life compared to generic measures in retinoblastoma survivors